NEW YORK (GenomeWeb) – Source BioScience yesterday reported that its revenues were flat year over year for the first half of 2015.

For the six-month period ended June 30, the UK-based lab services and molecular diagnostics firm reported total revenues of £12.8 million ($19.9 million), even with revenues reported for the first half of 2014.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Nuffield Council on Bioethics says genetically modifying human embryos could be morally permissible, according to the Guardian.

A new Nature Biotechnology paper reports that CRISPR-Cas9 gene editing can lead to large deletions or complex rearrangements that could be pathogenic.

The Wall Street Journal likens a prototype developed by Synthetic Genomics to a "biological fax machine."

In PNAS this week: strategy for reactivating Rett syndrome-linked MECP2, small molecules able to suppress Staphylococcus aureus virulence, and more.